In France, 50 mg of diclofenac epolamine granules for oral suspension in sachets have been granted marketing authorisation and are now available. The field of application extends over: short-term symptomatic treatment of acute seizures of extraarticular rheumatism such as scapulo-humerus periarthritis, tendonitis and mucosal inflammation in adolescents (over 15 years of age) and adults; microcrystalline arthritis; arthritis; Low Back Pain (lumbago); Radiculalgia